Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Clinimmune is a specialized biotechnology enterprise based at the University of Colorado Anschutz Medical Campus that provides comprehensive services in cell and gene therapy, histocompatibility (HLA), and cord blood banking. It operates as a high-complexity CLIA-certified and CAP-accredited laboratory, offering contract development and manufacturing (CDMO) services for advanced cellular therapeutics. The organization supports clinical trials and commercial products, including an FDA-licensed cord blood bank. Clinimmune is a key partner for academic researchers and biotech companies seeking to transition cell-based therapies from the bench to the bedside. Its facilities include state-of-the-art GMP cleanrooms designed for the production of CAR-T cells, stem cells, and other regenerative medicines.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on University of Colorado Clinimmune Labs.